相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The IL-15-Based ALT-803 Complex Enhances FcγRIIIa-Triggered NK Cell Responses and In Vivo Clearance of B Cell Lymphomas
Maximillian Rosario et al.
CLINICAL CANCER RESEARCH (2016)
Influence of the C5a-C5a receptor system on breast cancer progression and patient prognosis
Takahisa Imamura et al.
BREAST CANCER (2016)
IL35-Producing B Cells Promote the Development of Pancreatic Neoplasia
Yuliya Pylayeva-Gupta et al.
CANCER DISCOVERY (2016)
Cancer Immunotherapy with Immunomodulatory Anti-CD137 and Anti-PD-1 Monoclonal Antibodies Requires BATF3-Dependent Dendritic Cells
Alfonso R. Sanchez-Paulete et al.
CANCER DISCOVERY (2016)
Bruton Tyrosine Kinase-Dependent Immune Cell Cross-talk Drives Pancreas Cancer
Andrew J. Gunderson et al.
CANCER DISCOVERY (2016)
STING Promotes the Growth of Tumors Characterized by Low Antigenicity via IDO Activation
Henrique Lemos et al.
CANCER RESEARCH (2016)
New perspectives on complement mediated immunotherapy
Grzegorz Stasilojc et al.
CANCER TREATMENT REVIEWS (2016)
Microbiome and Anticancer Immunosurveillance
Laurence Zitvogel et al.
CELL (2016)
Tumor-Produced Interleukin-8 Attracts Human Myeloid-Derived Suppressor Cells and Elicits Extrusion of Neutrophil Extracellular Traps (NETs)
Carlos Alfaro et al.
CLINICAL CANCER RESEARCH (2016)
Innate lymphoid cells: parallel checkpoints and coordinate interactions with T cells
Nicholas D. Huntington et al.
CURRENT OPINION IN IMMUNOLOGY (2016)
C5a receptor enhances hepatocellular carcinoma cell invasiveness via activating ERK1/2-mediated epithelial-mesenchymal transition
Wen-Hao Hu et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2016)
CD5 Binds to Interleukin-6 and Induces a Feed-Forward Loop with the Transcription Factor STAT3 in B Cells to Promote Cancer
Chunyan Zhang et al.
IMMUNITY (2016)
Recognition of Endogenous Nucleic Acids by the Innate Immune System
Axel Roers et al.
IMMUNITY (2016)
In situ vaccination for the treatment of cancer
Linda Hammerich et al.
IMMUNOTHERAPY (2016)
Growing tumors induce a local STING dependent Type I IFN response in dendritic cells
Lisa Andzinsk et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
Carcinoma-astrocyte gap junctions promote brain metastasis by cGAMP transfer
Qing Chen et al.
NATURE (2016)
C1q acts in the tumour microenvironment as a cancer-promoting factor independently of complement activation
Roberta Bulla et al.
NATURE COMMUNICATIONS (2016)
PD-1hi Identifies a Novel Regulatory B-cell Population in Human Hepatoma That Promotes Disease Progression
Xiao Xiao et al.
CANCER DISCOVERY (2016)
Innate Immune Recognition of Cancer
Seng-Ryong Woo et al.
ANNUAL REVIEW OF IMMUNOLOGY VOL 33 (2015)
PTX3 Is an Extrinsic Oncosuppressor Regulating Complement-Dependent Inflammation in Cancer
Eduardo Bonavita et al.
CELL (2015)
CSF-1/CSF-1R targeting agents in clinical development for cancer therapy
Carola H. Ries et al.
CURRENT OPINION IN PHARMACOLOGY (2015)
Complement Is a Central Mediator of Radiotherapy-Induced Tumor-Specific Immunity and Clinical Response
Laura Surace et al.
IMMUNITY (2015)
Complement 5a Enhances Hepatic Metastases of Colon Cancer via Monocyte Chemoattractant Protein-1-mediated Inflammatory Cell Infiltration
Chunmei Piao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Redistribution, Hyperproliferation, Activation of Natural Killer Cells and CD8 T Cells, and Cytokine Production During First-in-Human Clinical Trial of Recombinant Human Interleukin-15 in Patients With Cancer
Kevin C. Conlon et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Pulmonary Alveolar Macrophages Contribute to the Premetastatic Niche by Suppressing Antitumor T Cell Responses in the Lungs
Sharad K. Sharma et al.
JOURNAL OF IMMUNOLOGY (2015)
Complement activation promotes colitis-associated carcinogenesis through activating intestinal IL-1β/IL-17A axis
C. Ning et al.
MUCOSAL IMMUNOLOGY (2015)
Complement, a target for therapy in inflammatory and degenerative diseases
B. Paul Morgan et al.
NATURE REVIEWS DRUG DISCOVERY (2015)
Therapeutic approaches to enhance natural killer cell cytotoxicity against cancer: the force awakens
Richard W. Childs et al.
NATURE REVIEWS DRUG DISCOVERY (2015)
Chimeric Antigen Receptor T Cells against CD19 for Multiple Myeloma
Alfred L. Garfall et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Diverse roles of STING-dependent signaling on the development of cancer
J. Ahn et al.
ONCOGENE (2015)
Complement activation product C4d in oral and oropharyngeal squamous cell carcinoma
D. Ajona et al.
ORAL DISEASES (2015)
STING activation of tumor endothelial cells initiates spontaneous and therapeutic antitumor immunity
Olivier Demaria et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Phosphorylation of innate immune adaptor proteins MAVS, STING, and TRIF induces IRF3 activation
Siqi Liu et al.
SCIENCE (2015)
Direct Activation of STING in the Tumor Microenvironment Leads to Potent and Systemic Tumor Regression and Immunity
Leticia Corrales et al.
CELL REPORTS (2015)
Virotherapy with a Semliki Forest Virus-Based Vector Encoding IL12 Synergizes with PD-1/PD-L1 Blockade
Jose I. Quetglas et al.
CANCER IMMUNOLOGY RESEARCH (2015)
NKG2D Receptor and Its Ligands in Host Defense
Lewis L. Lanier
CANCER IMMUNOLOGY RESEARCH (2015)
Complement system part II: role in immunity
Nicolas S. Merle et al.
FRONTIERS IN IMMUNOLOGY (2015)
NK cell-mediated antibody-dependent cellular cytotoxicity in cancer immunotherapy
Wei Wang et al.
FRONTIERS IN IMMUNOLOGY (2015)
Complement system part I - molecular mechanisms of activation and regulation
Nicolas S. Merle et al.
FRONTIERS IN IMMUNOLOGY (2015)
Curing Mice with Large Tumors by Locally Delivering Combinations of Immunomodulatory Antibodies
Min Dai et al.
CLINICAL CANCER RESEARCH (2015)
Elevated Levels of the Complement Activation Product C4d in Bronchial Fluids for the Diagnosis of Lung Cancer
Daniel Ajona et al.
PLoS One (2015)
Anti-KIR antibody enhancement of anti-lymphoma activity of natural killer cells as monotherapy and in combination with anti-CD20 antibodies
Holbrook E. Kohrt et al.
BLOOD (2014)
B Cells Regulate Macrophage Phenotype and Response to Chemotherapy in Squamous Carcinomas
Nesrine I. Affara et al.
CANCER CELL (2014)
Complement C5a Receptor Facilitates Cancer Metastasis by Altering T-Cell Responses in the Metastatic Niche
Surya Kumari Vadrevu et al.
CANCER RESEARCH (2014)
Complement Pathway Is Frequently Altered in Endometriosis and Endometriosis-Associated Ovarian Cancer
Swati Suryawanshi et al.
CLINICAL CANCER RESEARCH (2014)
Serum Interleukin-8 Reflects Tumor Burden and Treatment Response across Malignancies of Multiple Tissue Origins
Miguel F. Sanmamed et al.
CLINICAL CANCER RESEARCH (2014)
STING-Dependent Cytosolic DNA Sensing Mediates Innate Immune Recognition of Immunogenic Tumors
Seng-Ryong Woo et al.
IMMUNITY (2014)
被撤回的出版物: Targeting CD137 enhances the efficacy of cetuximab (Retracted article. See vol. 129, pg. 2595, 2019)
Holbrook E. Kohrt et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Effective Innate and Adaptive Antimelanoma Immunity through Localized TLR7/8 Activation
Manisha Singh et al.
JOURNAL OF IMMUNOLOGY (2014)
STING-Mediated DNA Sensing Promotes Antitumor and Autoimmune Responses to Dying Cells
Jared Klarquist et al.
JOURNAL OF IMMUNOLOGY (2014)
Human complement C3 deficiency: Th1 induction requires T cell-derived complement C3a and CD46 activation
Arije Ghannam et al.
MOLECULAR IMMUNOLOGY (2014)
cC1qR/CR and gC1qR/p33: Observations in cancer
Ellinor I. B. Peerschke et al.
MOLECULAR IMMUNOLOGY (2014)
Ultra-low Dose Interleukin-2 Promotes Immune-modulating Function of Regulatory T Cells and Natural Killer Cells in Healthy Volunteers
Sawa Ito et al.
MOLECULAR THERAPY (2014)
Regulation of complement and modulation of its activity in monoclonal antibody therapy of cancer
Saskia Meyer et al.
MABS (2014)
C3 opsonization regulates endocytic handling of apoptotic cells resulting in enhanced T-cell responses to cargo-derived antigens
Lucie Baudino et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
C1q as a unique player in angiogenesis with therapeutic implication in wound healing
Fleur Bossi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
STING-dependent cytosolic DNA sensing pathways
Glen N. Barber
TRENDS IN IMMUNOLOGY (2014)
Inflammation-driven carcinogenesis is mediated through STING
Jeonghyun Ahn et al.
NATURE COMMUNICATIONS (2014)
Autocrine Effects of Tumor-Derived Complement
Min Soon Cho et al.
CELL REPORTS (2014)
Transient Complement Inhibition Promotes a Tumor-Specific Immune Response through the Implication of Natural Killer Cells
Valerie Janelle et al.
CANCER IMMUNOLOGY RESEARCH (2014)
STING Contributes to Antiglioma Immunity via Triggering Type I IFN Signals in the Tumor Microenvironment
Takayuki Ohkuri et al.
CANCER IMMUNOLOGY RESEARCH (2014)
STING Ligand c-di-GMP Improves Cancer Vaccination against Metastatic Breast Cancer
Dinesh Chandra et al.
CANCER IMMUNOLOGY RESEARCH (2014)
Role of the complement system in NK cell-mediated antitumor T-cell responses
Valerie Janelle et al.
ONCOIMMUNOLOGY (2014)
Anticancer Flavonoids Are Mouse-Selective STING Agonists
Sujeong Kim et al.
ACS CHEMICAL BIOLOGY (2013)
Antitumor Immunotherapeutic and Toxic Properties of an HDL-Conjugated Chimeric IL-15 Fusion Protein
Maria C. Ochoa et al.
CANCER RESEARCH (2013)
Structure-Function Analysis of STING Activation by c[G(2′,5′) pA(3′,5′)p] and Targeting by Antiviral DMXAA
Pu Gao et al.
CELL (2013)
Enhancement of Human Cancer Cell Motility and Invasiveness by Anaphylatoxin C5a via Aberrantly Expressed C5a Receptor (CD88)
Hidetoshi Nitta et al.
CLINICAL CANCER RESEARCH (2013)
Complement C4 maintains peripheral B-cell tolerance in a myeloid cell dependent manner
Priyadarshini Chatterjee et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2013)
Anticancer Chemotherapy-Induced Intratumoral Recruitment and Differentiation of Antigen-Presenting Cells
Yuting Ma et al.
IMMUNITY (2013)
Mouse, but not Human STING, Binds and Signals in Response to the Vascular Disrupting Agent 5,6-Dimethylxanthenone-4-Acetic Acid
Joseph Conlon et al.
JOURNAL OF IMMUNOLOGY (2013)
Complement in Immune and Inflammatory Disorders: Therapeutic Interventions
Daniel Ricklin et al.
JOURNAL OF IMMUNOLOGY (2013)
Investigation of Complement Activation Product C4d as a Diagnostic and Prognostic Biomarker for Lung Cancer
Daniel Ajona et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2013)
Overexpression of CD88 predicts poor prognosis in non-small-cell lung cancer
Jie Gu et al.
LUNG CANCER (2013)
Absence of signaling into CD4+ cells via C3aR and C5aR enables autoinductive TGF-β1 signaling and induction of Foxp3+ regulatory T cells
Michael G. Strainic et al.
NATURE IMMUNOLOGY (2013)
STING and the innate immune response to nucleic acids in the cytosol
Dara L. Burdette et al.
NATURE IMMUNOLOGY (2013)
The Ultra-Potent and Selective TLR8 Agonist VTX-294 Activates Human Newborn and Adult Leukocytes
David J. Dowling et al.
PLOS ONE (2013)
Cyclic GMP-AMP Is an Endogenous Second Messenger in Innate Immune Signaling by Cytosolic DNA
Jiaxi Wu et al.
SCIENCE (2013)
Cyclic GMP-AMP Synthase Is a Cytosolic DNA Sensor That Activates the Type I Interferon Pathway
Lijun Sun et al.
SCIENCE (2013)
The role of complement in CD4+ T cell homeostasis and effector functions
Martin Kolev et al.
SEMINARS IN IMMUNOLOGY (2013)
Complement inhibition in cancer therapy
Ruben Pio et al.
SEMINARS IN IMMUNOLOGY (2013)
Pathological mobilization and activities of dendritic cells in tumor-bearing hosts: challenges and opportunities for immunotherapy of cancer
Amelia J. Tesone et al.
FRONTIERS IN IMMUNOLOGY (2013)
Early onset and enhanced growth of autochthonous mammary carcinomas in C3-deficient Her2/neu transgenic mice
Silvio Bandini et al.
ONCOIMMUNOLOGY (2013)
Complement activation in astrocytomas: deposition of C4d and patient outcome
Katri Makela et al.
BMC CANCER (2012)
LIGHT Delivery to Tumors by Mesenchymal Stem Cells Mobilizes an Effective Antitumor Immune Response
Weibin Zou et al.
CANCER RESEARCH (2012)
Coxsackievirus B3 Is an Oncolytic Virus with Immunostimulatory Properties That Is Active against Lung Adenocarcinoma
Shohei Miyamoto et al.
CANCER RESEARCH (2012)
Fc gamma receptor polymorphisms as predictive markers of Cetuximab efficacy in epidermal growth factor receptor downstream-mutated metastatic colorectal cancer
Javier Rodriguez et al.
EUROPEAN JOURNAL OF CANCER (2012)
Eradication of large tumors expressing human papillomavirus E7 protein by therapeutic vaccination with E7 fused to the extra domain a from fibronectin
Cristina Mansilla et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
5,6-Dimethylxanthenone-4-acetic Acid (DMXAA) Activates Stimulator of Interferon Gene (STING)-dependent Innate Immune Pathways and Is Regulated by Mitochondrial Membrane Potential
Daniel Prantner et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Anaphylatoxin C5a Creates a Favorable Microenvironment for Lung Cancer Progression
Leticia Corrales et al.
JOURNAL OF IMMUNOLOGY (2012)
Opposing Roles for Complement Component C5a in Tumor Progression and the Tumor Microenvironment
Lacey Gunn et al.
JOURNAL OF IMMUNOLOGY (2012)
The current status of cancer biomarker research using tumour-associated antigens for minimal invasive and early cancer diagnostics
Johana A. Luna Coronell et al.
JOURNAL OF PROTEOMICS (2012)
Exploiting a natural conformational switch to engineer an interleukin-2 'superkine'
Aron M. Levin et al.
NATURE (2012)
IL-22BP is regulated by the inflammasome and modulates tumorigenesis in the intestine
Samuel Huber et al.
NATURE (2012)
Immune Tolerance to Tumor Antigens Occurs in a Specialized Environment of the Spleen
Stefano Ugel et al.
CELL REPORTS (2012)
Genetic and Pharmacologic Inhibition of Complement Impairs Endothelial Cell Function and Ablates Ovarian Cancer Neovascularization
Selene Nunez-Cruz et al.
NEOPLASIA (2012)
Natural Innate and Adaptive Immunity to Cancer
Matthew D. Vesely et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 29 (2011)
Adoptive immunotherapy combined with intratumoral TLR agonist delivery eradicates established melanoma in mice
Sally M. Amos et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2011)
The Efficacy of Radiotherapy Relies upon Induction of Type I Interferon-Dependent Innate and Adaptive Immunity
Byron C. Burnette et al.
CANCER RESEARCH (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
IL-15:IL-15 receptor alpha superagonist complex: High-level co-expression in recombinant mammalian cells, purification and characterization
Kai-Ping Han et al.
CYTOKINE (2011)
Oxaliplatin in combination with liver-specific expression of interleukin 12 reduces the immunosuppressive microenvironment of tumours and eradicates metastatic colorectal cancer in mice
Manuela Gonzalez-Aparicio et al.
GUT (2011)
Interleukin (IL)-2 and IL-15 have different effects on human natural killer lymphocytes
Anne-Helene Pillet et al.
HUMAN IMMUNOLOGY (2011)
Randomized Phase III Placebo-Controlled Trial of Carboplatin and Paclitaxel With or Without the Vascular Disrupting Agent Vadimezan (ASA404) in Advanced Non-Small-Cell Lung Cancer
Primo N. Lara et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Host type I IFN signals are required for antitumor CD8+ T cell responses through CD8α+ dendritic cells
Mercedes B. Fuertes et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Synthetic double-stranded RNA induces innate immune responses similar to a live viral vaccine in humans
Marina Caskey et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Successful Colon Cancer Eradication after Chemoimmunotherapy Is Associated with Profound Phenotypic Change of Intratumoral Myeloid Cells
Jose Medina-Echeverz et al.
JOURNAL OF IMMUNOLOGY (2011)
Pilot Clinical Trial of Type 1 Dendritic Cells Loaded with Autologous Tumor Lysates Combined with GM-CSF, Pegylated IFN, and Cyclophosphamide for Metastatic Cancer Patients
Carlos Alfaro et al.
JOURNAL OF IMMUNOLOGY (2011)
Selenite Induces Posttranscriptional Blockade of HLA-E Expression and Sensitizes Tumor Cells to CD94/NKG2A-Positive NK Cells
Monika Enqvist et al.
JOURNAL OF IMMUNOLOGY (2011)
STING is a direct innate immune sensor of cyclic di-GMP
Dara L. Burdette et al.
NATURE (2011)
Carcinoma-Derived Interleukin-8 Disorients Dendritic Cell Migration Without Impairing T-Cell Stimulation
Carlos Alfaro et al.
PLOS ONE (2011)
B regulatory cells and the tumor-promoting actions of TNF-α during squamous carcinogenesis
Tiziana Schioppa et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
The complexity of HDL
Gordon A. Francis
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2010)
FcRγ Activation Regulates Inflammation-Associated Squamous Carcinogenesis
Pauline Andreu et al.
CANCER CELL (2010)
Complement Factor H Is Elevated in Bronchoalveolar Lavage Fluid and Sputum from Patients with Lung Cancer
Ruben Pio et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2010)
CD16 cross-linking induces increased expression of CD56 and production of IL-12 in peripheral NK cells
Maria-Elena Marquez et al.
CELLULAR IMMUNOLOGY (2010)
The biology of myeloid-derived suppressor cells: The blessing and the curse of morphological and functional heterogeneity
Je-In Youn et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2010)
In Situ Vaccination With a TLR9 Agonist Induces Systemic Lymphoma Regression: A Phase I/II Study
Joshua D. Brody et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
HIF-1α regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment
Cesar A. Corzo et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
MyD88-mediated signaling prevents development of adenocarcinomas of the colon: role of interleukin 18
Rosalba Salcedo et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Promoting Immune Responses by LIGHT in the Face of Abundant Regulatory T Cell Inhibition
Yugang Wang et al.
JOURNAL OF IMMUNOLOGY (2010)
Mechanism of T Cell Tolerance Induced by Myeloid-Derived Suppressor Cells
Srinivas Nagaraj et al.
JOURNAL OF IMMUNOLOGY (2010)
Pivotal Advance: The pattern recognition receptor ligands lipopolysaccharide and polyinosine-polycytidylic acid stimulate factor B synthesis by the macrophage through distinct but overlapping mechanisms
David J. Kaczorowski et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2010)
Complement: a key system for immune surveillance and homeostasis
Daniel Ricklin et al.
NATURE IMMUNOLOGY (2010)
Safety and immunologic effects of IL-15 administration in nonhuman primates
Carolina Berger et al.
BLOOD (2009)
Hypoxia increases susceptibility of non-small cell lung cancer cells to complement attack
Marcin Okroj et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
Chemokine Expression in Melanoma Metastases Associated with CD8+ T-Cell Recruitment
Helena Harlin et al.
CANCER RESEARCH (2009)
The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans
Cameron S. Brandt et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
A host type I interferon response is induced by cytosolic sensing of the bacterial second messenger cyclic-di-GMP
Sarah M. McWhirter et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation
G. Solinas et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2009)
Regression of Established AB1 Murine Mesothelioma Induced by Peritumoral Injections of CpG Oligodeoxynucleotide Either Alone or in Combination with Poly(I:C) and CD40 Ligand Plasmid DNA
Geoffrey W. Stone et al.
JOURNAL OF THORACIC ONCOLOGY (2009)
The role of the anaphylatoxins in health and disease
Andreas Klos et al.
MOLECULAR IMMUNOLOGY (2009)
STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity
Hiroki Ishikawa et al.
NATURE (2009)
Myeloid-derived suppressor cells as regulators of the immune system
Dmitry I. Gabrilovich et al.
NATURE REVIEWS IMMUNOLOGY (2009)
Systemic targeting of CpG-ODN to the tumor microenvironment with anti-neu-CpG hybrid molecule and T regulatory cell depletion induces memory responses in BALB-neuT tolerant mice
Sanjay Sharma et al.
CANCER RESEARCH (2008)
Locally produced complement fragments C5a and C3a provide both costimulatory and survival signals to naive CD4+ T cells
Michael G. Strainic et al.
IMMUNITY (2008)
Immunoglobulin G fragment C receptor polymorphisms and clinical efficacy of trastuzumab-based therapy in patients with HER-2/neu-positive metastatic breast cancer
Antonino Musolino et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
TLR Ligands in the Local Treatment of Established Intracerebral Murine Gliomas
Oliver M. Grauer et al.
JOURNAL OF IMMUNOLOGY (2008)
Non-small cell lung cancer cells produce a functional set of complement factor I and its soluble cofactors
Marcin Okroj et al.
MOLECULAR IMMUNOLOGY (2008)
STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling
Hiroki Ishikawa et al.
NATURE (2008)
Natural killer cell recognition of missing self
Klas Karre
NATURE IMMUNOLOGY (2008)
Modulation of the antitumor immune response by complement
Maciej M. Markiewski et al.
NATURE IMMUNOLOGY (2008)
Local production and activation of complement up-regulates the allostimulatory function of dendritic cells through C3a-C3aR interaction
Qi Peng et al.
BLOOD (2008)
Eradication of large tumors in mice by a tritherapy targeting the innate, adaptive, and regulatory components of the immune system
Pedro Berraondo et al.
CANCER RESEARCH (2007)
Regulation of Toll-like receptor-mediated inflammatory response by complement in vivo
Xinhua Zhang et al.
BLOOD (2007)
Down-regulation of human complement factor h sensitizes non-small cell lung cancer cells to complement attack and reduces in vivo tumor growth
Daniel Ajona et al.
JOURNAL OF IMMUNOLOGY (2007)
Inflammation, cancer and chemoresistance: Taking advantage of the toll-like receptor signaling pathway
Rui Chen et al.
AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY (2007)
Significance of C4d deposition in the follicular lymphoma and MALT lymphoma and their relationship with follicular dendritic cells
Xianmin Bu et al.
PATHOLOGY RESEARCH AND PRACTICE (2007)
Tumor and viral recognition by natural killer cells receptors
Tal I. Arnon et al.
SEMINARS IN CANCER BIOLOGY (2006)
Expression of the membrane complement regulatory protein CD59 (protectin) is associated with reduced survival in colorectal cancer patients
NFS Watson et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2006)
Dendritic cell synthesis of C3 is required for full T cell activation and development of a Th1 phenotype
Qi Peng et al.
JOURNAL OF IMMUNOLOGY (2006)
Pathogen recognition and innate immunity
S Akira et al.
CELL (2006)
Cell-derived anaphylatoxins as key mediators of anti body-dependent type II autoimmunity in mice
V Kumar et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
NKG2D function protects the host from tumor initiation
MJ Smyth et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Dendritic cells delivered inside human carcinomas are sequestered by interleukin-8
E Feijoó et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Natural killer cell-mediated lysis of hepatoma cells via specific induction of NKG2D Ligands by the histone deacetylase inhibitor sodium valproate
S Armeanu et al.
CANCER RESEARCH (2005)
De novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependent
KE de Visser et al.
CANCER CELL (2005)
Complement factor H as a marker for detection of bladder cancer
ZZ Cheng et al.
CLINICAL CHEMISTRY (2005)
Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer
JS Miller et al.
BLOOD (2005)
Immunosuppressive networks in the tumour environment and their therapeutic relevance
WP Zou
NATURE REVIEWS CANCER (2005)
Smoldering and polarized inflammation in the initiation and promotion of malignant disease
F Balkwill et al.
CANCER CELL (2005)
The complement inhibitory protein DAF (CD55) suppresses T cell immunity in vivo
JN Liu et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Increased CD59 protein expression predicts a PSA relapse in patients after radical prostatectomy
CL Xu et al.
PROSTATE (2005)
Do poor-prognosis breast tumours express membrane cofactor proteins (CD46)?
Z Madjd et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2005)
Phase I trial of intratumoral injection of an adenovirus encoding interleukin-12 for advanced digestive tumors
B Sangro et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Innate immune surveillance of spontaneous B cell lymphomas by natural killer cells and γδ T cells
SEA Street et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Analysis of the level of mRNA expression of the membrane regulators of complement, Cd59, Cd55 and Cd46, in breast, cancer
NK Rushmere et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Expression of complement factor H by lung cancer cells:: Effects on the activation of the alternative pathway of complement
D Ajona et al.
CANCER RESEARCH (2004)
Increased activity of the mannan-binding lectin complement activation pathway in patients with colorectal cancer
H Ytting et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2004)
Early neoplastic progression is complement independent
KE de Visser et al.
NEOPLASIA (2004)
Evasion from NK cell immunity by MHC class I chain-related molecules expressing colon adenocarcinoma
ES Doubrovina et al.
JOURNAL OF IMMUNOLOGY (2003)
Enhanced expression of the complement regulatory protein CD55 predicts a poor prognosis in colorectal cancer patients
LG Durrant et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2003)
Phase I trial of concurrent twice-weekly recombinant human interleukin-12 plus low-dose IL-2 in patients with melanoma or renal cell carcinoma
JA Gollob et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Tolerance is dependent on complement C3 fragment iC3b binding to antigen-presenting cells
JH Sohn et al.
NATURE MEDICINE (2003)
The absence of fucose but not the presence of galactose or bisecting N-acetylglucosamine of human IgG1 complex-type oligosaccharides shows the critical role of enhancing antibody-dependent cellular cytotoxicity
T Shinkawa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Activation of human CD4+ cells with CD3 and CD46 induces a T-regulatory cell 1 phenotype
C Kemper et al.
NATURE (2003)
Secretion of soluble complement inhibitors factor H and factor H-like protein (FHL-I) by ovarian tumour cells
S Junnikkalla et al.
BRITISH JOURNAL OF CANCER (2002)
Autocrine and/or paracrine growth of adult T-cell leukaemia tumour cells by interleukin 15
T Kukita et al.
BRITISH JOURNAL OF HAEMATOLOGY (2002)
Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation
V Groh et al.
NATURE (2002)
The danger model: A renewed sense of self
P Matzinger
SCIENCE (2002)
Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants
L Ruggeri et al.
SCIENCE (2002)
Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcγRIIIa gene
G Cartron et al.
BLOOD (2002)
The allogeneic T and B cell response is strongly dependent on complement components C3 and C4
JE Marsh et al.
TRANSPLANTATION (2001)
TRAIL/Apo2L ligand selectively induces apoptosis and overcomes drug resistance in multiple myeloma: therapeutic applications
CS Mitsiades et al.
BLOOD (2001)
Contribution of the innate immune system to autoimmune myocarditis: a role for complement
Z Kaya et al.
NATURE IMMUNOLOGY (2001)
Thalidomide and immunomodulatory derivatives augment natural killer cell cytotoxicity in multiple myeloma
FE Davies et al.
BLOOD (2001)
The role of the CD19/CD21 complex in B cell processing and presentation of complement-tagged antigens
A Cherukuri et al.
JOURNAL OF IMMUNOLOGY (2001)
Intratumoral injection of lipopolysaccharide causes regression of subcutaneously implanted mouse glioblastoma multiforme
MR Chicoine et al.
NEUROSURGERY (2001)
C-reactive protein binds to apoptotic cells, protects the cells from assembly of the terminal complement components, and sustains an antiinflammatory innate immune response: Implications for systemic autoimmunity
D Gershov et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Exceptional resistance of human H2 glioblastoma cells to complement-mediated killing by expression and utilization of factor H and factor H-like protein 1
S Junnikkala et al.
JOURNAL OF IMMUNOLOGY (2000)
分享论文
